摘要
目的:评价3种无痛苦胃镜麻醉方案的经济学效果。方法:对381例无痛苦胃镜检查患者3种麻醉方案(咪达唑仑+哌替啶,A组,137例;芬太尼+丙泊酚,B组,146例;丙泊酚,C组,98例)进行疗效观察,并运用药物经济学方法进行最小成本分析。结果:A、B、C组麻醉疗效及并发症差异无统计学意义(P>0.05),药物成本分别为20.0、39.3、46.0元(P<0.01)。结论:从药物经济学分析,A组麻醉方案最佳。
OBJECTIVE： To evaluate pharmacoeconomic effects of 3 anesthesia schemes for painless gastroscopy. METHODS： 381 patients underwent painless gastroscopy were injected with midazolam and meperidine （Group A, n=137） or fentanyl and propofol （Group B,n=146） or propofol （Group C,n=98）, respectively. Curative effect was recorded and cost-minimization was analyzed using pharmacoeconomics. RESULTS： The curative effect and complication of 3 groups were not statistically significant （P〉0.05）. The costs of Group A, B and C were 20.0 yuan, 39.3 yuan and 46.0 yuan, respectively（P〈0.01）. CONCLUSION： Regime A is the optimal therapeutic regimen in perspective of pharmacoeconomics.
出处
《中国药房》
CAS
CSCD
北大核心
2010年第6期484-486,共3页
China Pharmacy
关键词
胃镜
麻醉
药物治疗方案
最小成本分析
Gastroscopy
Anesthesia
Therapeutic regimen
Cost-minimization analysis
